Open-Label Placebo for Functional Dyspepsia

Status

Terminated

Phases

Early Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03745781

Enrollment

Registered

2018-11-19

Start date

2018-12-01

Completion date

2019-10-07

Last updated

2020-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspepsia

Brief summary

The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.

Interventions

DRUGPlacebos

placebo pills

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

Arm 1: open-label placebo Arm 2: treatment as usual control

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Functional Dyspepsia

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
dyspepsia severity on a VAS from 0-100	3 weeks	How severe have your dyspepsia symptoms been over the past 7 days (on a VAS from 0-100)?

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026